Research Coverage- Viking Therapeutics (VKTX)
This is meant as a scientific/business development post as to the merits of VKTX. It is well known VKTX is undervalued (by upwards of 40x), but these details will not be discussed here. For a more detailed valuation analysis, see the end of Zacks SCR’s post.
Viking Therapeutics is a clinical stage biopharmaceutical....More>>>
Rising short interest indicates investors are betting against Apple Inc (NASDAQ:AAPL) stock due to rich valuation.
In the year-to-date period, shares of Cupertino based iPhone maker, Apple Inc (NASDAQ:AAPL) have rallied by over 50%. While this is a massive rally for any company, but, given the size of Apple Inc, this rally is even more impressive. Apple Inc added close to $285....More>>>
Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.
Share Price (US)
FD Mkt Cap (4/3/2017)
It’s been an interesting few years for T-shirt manufacturer Delta Apparel (NYSEMKT:DLA). A huge spike in cotton prices in 2011 helped turn a near-$2 EPS in FY11 into a loss in FY12. (DLA fiscal years then ended in June; the company moved to September in 2013.) Delta managed to recover in FY13, getting EPS back over $1 – and then the company’s Soffe brand started falling apart,....More>>>
Billionaire hedge fund Bill Ackman has sold his disastrous stake in Valeant Pharmaceuticals International and said he won’t seek re-election to the drugmaker’s board, bowing outas the value of the company’s shares remains at longtime lows.
Disclosed after U.S. financial markets closed Monday, the announcement sent Valeant (VRX) shares down roughly 10%to $10.90 in after-hours....More>>>